Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician's choice in cutaneous T-cell lymphoma: Final data

1. Horwitz, S.M.
2. Scarisbrick, J.J.
3. Dummer, R.
4. Whittaker, S.
5. Duvic, M.
6. Kim, Y.H.
7. Quaglino, P.
8. Zinzani, P.L.
9. Bechter, O.
10. Eradat, H.
11. Pinter-Brown, L.
12. Akilov, O.E.
13. Geskin, L.
14. Sanches, J.A.
15. Ortiz-Romero, P.L.
16. Weichenthal, M.
17. Fisher, D.C.
18. Walewski, J.
19. Trotman, J.
20. Taylor, K.
21. Dalle, S.
22. Stadler, R.
23. Lisano, J.
24. Bunn, V.
25. Little, M.
26. Miles Prince, H.
27. Show all authors +

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1182/BLOODADVANCES.2021004710 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus